FULLY Repeal ObamaCare - April 2017

On behalf of FreedomWorks’ activist community, I urge you to contact your representative and ask him or her to support the Creating and Restoring Equal Access To Equivalent Samples (CREATES) Act, S. 974 and H.R. 2212. This bill would lower prescription drug prices by crushing illegal, anti-competitive, and monopolistic practices by the biggest pharmaceutical companies.

On behalf of FreedomWorks activists nationwide, I urge you to contact your representative and encourage him or her to cosponsor the Prison Reform and Redemption Act, H.R. 3356, introduced by Rep. Doug Collins (R-Ga.). This bill would require the Attorney General to develop an offender risk and needs assessment system and incentivizes offenders to lower their risk of recidivism.

Perpetually increasing prescription drug prices ravage everyday Americans. Specifically, name-brand prices outpace inflation by about 50%, largely due to government-protected market power. A beacon of hope for reducing drug prices are the generic and biosimilar drug industries, which produces existing brand drugs and biologics drugs through distinctly cheaper methods. But big Pharma doesn’t want competition, so it does everything it can to block generic and biosimilar innovation. The CREATES Act, H.R. 2212, solves a loophole commonly abused by big pharmaceutical companies for unlawful market advantages in the emerging generics and biosimilars markets.

Over the past several months, Attorney General Jeff Sessions has taken a step back on federal justice reform efforts, regressing to purportedly “tough on crime” stances. From advising increased penalties for nonviolent offenders to more recently promising an increase in the use of civil asset forfeiture by the federal government, Sessions has been doing everything in his power to give the Department of Justice (DOJ)’s full support to 80s-era policies from which many conservatives have abandoned in favor of evidenced-based practices that reduce recidivism and enhance public safety.

The House and Senate are in session this week.